21st Bio€quity Europe

May 17, 2021

May 19, 2021

10:00 am To 4:45 pm

Online: BST (UK)


See website for fee details

Event Description

Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs

Europe’s Next Act
European innovators helped pave the way for the world’s first COVID-19 vaccines. What’s coming next from Europe’s academic and biotech leaders?

What are the weathervane companies that point to where European innovation is headed?
What partnering deals are making the European highlight reel?
What innovations are investors finding and funding in Europe?
Can the U.K.’s split from the EU foster new opportunities for each side?
Join your colleagues for the 21st Bio€quity Europe as industry leaders debate these questions and identify where Europe will continue to provide global leadership in biopharma innovation.




About the Organizers

BioCentury provides analysis on biopharma, relevant news. Driven by our primary research, original reporting and rigorous editorial process. Now in its 17th Year, BioCentury is recognized as the ESSENTIAL provider of independent, informed business intelligence that regularly affects decisions made by bio-industry leaders and investors throughout the world. BioCentury's mission is to provide value-added information and analysis for biotech and pharma companies, investors, academia and government on the strategic issues essential to the formation, development and sustainability of biopharmaceutical ventures.

Visited 58 times, 1 Visit today